Haidar Ahmad S, Al Moussawi F, El Baba R, Nehme Z, Pasquereau S, Kumar A, Molimard C, Monnien F, Algros MP, Karaky R, Stamminger T, Diab Assaf M, Herbein G

Front Oncol. 2021 ;11:627866

Immune Landscape of CMV Infection in Cancer Patients: From "Canonical" Diseases Toward Virus-Elicited Oncomodulation.

El Baba R, Herbein G

Front Immunol. 2021 ;12:730765

Management of epigenomic networks entailed in coronavirus infections and COVID-19.

El Baba R, Herbein G

Clin Epigenetics. 2020 Aug 5;12(1):118

Shock and kill, but don't miss the target.

Herbein G

EBioMedicine. 2020 Jul 21;58:102906

Impact of glucocorticoids on systemic sirtuin 1 expression and activity in rats with adjuvant-induced arthritis.

Pasquereau S, Totoson P, Nehme Z, Abbas W, Kumar A, Verhoeven F, Prati C, Wendling D, Demougeot C, Herbein G

Epigenetics. 2020 Jul 2;:

Tumor Control by Cytomegalovirus: A Door Open for Oncolytic Virotherapy?

Herbein G, Nehme Z

Mol Ther Oncolytics. 2020 Jun 26;17:1-8

Polyploid Giant Cancer Cells, a Hallmark of Oncoviruses and a New Therapeutic Challenge.

Herbein G, Nehme Z

Front Oncol. 2020 ;10:567116

Control of viral infections by epigenetic-targeted therapy.

Nehme Z, Pasquereau S, Herbein G

Clin Epigenetics. 2019 Mar 27;11(1):55

Impact of Cytomegalovirus Infection on the Outcome of Patients With Cirrhosis: A Preliminary Study.

Faivre M, Cottet V, Bour JB, Richou C, Valmary-Degano S, Thiefin G, Andreoletti L, Geist C, Schvoerer E, Malvé B, Habersetzer F, Fafi-Kremer S, Binquet C, Jouve JL, Bronowicki JP, Doffoel M, Hillon P, Herbein G, Monnet E, Di Martino V,

J. Clin. Gastroenterol.. 2018 Oct 31;:

The transcriptome of human mammary epithelial cells infected with the HCMV-DB strain displays oncogenic traits.

Moussawi FA, Kumar A, Pasquereau S, Tripathy MK, Karam W, Diab-Assaf M, Herbein G

Sci Rep. 2018 Aug 22;8(1):12574

The Human Cytomegalovirus, from Oncomodulation to Oncogenesis.

Herbein G

Viruses. 2018 Aug 3;10(8):

Counteracting Akt Activation by HIV Protease Inhibitors in Monocytes/Macrophages.

Pasquereau S, Kumar A, Abbas W, Herbein G

Viruses. 2018 04 13;10(4):

The Human Cytomegalovirus Strain DB Activates Oncogenic Pathways in Mammary Epithelial Cells.

Kumar A, Tripathy MK, Pasquereau S, Al Moussawi F, Abbas W, Coquard L, Khan KA, Russo L, Algros MP, Valmary-Degano S, Adotevi O, Morot-Bizot S, Herbein G

EBioMedicine. 2018 Apr;30:167-183

Targeting TNF and TNF Receptor Pathway in HIV-1 Infection: from Immune Activation to Viral Reservoirs.

Pasquereau S, Kumar A, Herbein G

Viruses. 2017 Mar;9(4):

Cellular Senescence, Immunosenescence and HIV.

Fülöp T, Herbein G, Cossarizza A, Witkowski JM, Frost E, Dupuis G, Pawelec G, Larbi A

Interdiscip Top Gerontol Geriatr. 2017 ;42:28-46

Limited HIV-1 Reactivation in Resting CD4(+) T cells from Aviremic Patients under Protease Inhibitors.

Kumar A, Abbas W, Bouchat S, Gatot JS, Pasquereau S, Kabeya K, Clumeck N, De Wit S, Van Lint C, Herbein G

Sci Rep. 2016 Dec;6:38313

TNF and HIV-1 Nef: An Intimate Interplay.

Herbein G

EBioMedicine. 2016 Nov;13:25-26

Main biomarkers associated with age-related plasma zinc decrease and copper/zinc ratio in healthy elderly from ZincAge study.

Giacconi R, Costarelli L, Piacenza F, Basso A, Rink L, Mariani E, Fulop T, Dedoussis G, Herbein G, Provinciali M, Jajte J, Lengyel I, Mocchegiani E, Malavolta M

Eur J Nutr. 2016 Jul;:

Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line.

Kumar A, Abbas W, Colin L, Khan KA, Bouchat S, Varin A, Larbi A, Gatot JS, Kabeya K, Vanhulle C, Delacourt N, Pasquereau S, Coquard L, Borch A, König R, Clumeck N, De Wit S, Rohr O, Rouzioux C, Fulop T, Van Lint C, Herbein G

Sci Rep. 2016 Apr;6:24090

Targeting TNF-Alpha in HIV-1 Infection.

Kumar A, Coquard L, Herbein G

Curr Drug Targets. 2016 ;17(1):15-22

Tumor control by human cytomegalovirus in a murine model of hepatocellular carcinoma.

Kumar A, Coquard L, Pasquereau S, Russo L, Valmary-Degano S, Borg C, Pothier P, Herbein G

Mol Ther Oncolytics. 2016 ;3:16012

The alternative CD20 transcript variant is not a surrogate marker for resistance to rituximab in patients with rheumatoid arthritis.

Gamonet C, Deschamps M, Marion S, Herbein G, Chiocchia G, Auger I, Saas P, Ferrand C, Toussirot E

Rheumatology (Oxford). 2015 Sep;54(9):1744-5

Sirt-1 activity in PBMC from patients with spondyloarthritis.

Wendling D, Delattre E, Abbas W, Guillot X, Toussirot E, Herbein G

Joint Bone Spine. 2015 May;82(3):210-1

Eradication of HIV-1 from the macrophage reservoir: an uncertain goal?

Abbas W, Tariq M, Iqbal M, Kumar A, Herbein G

Viruses. 2015 Mar;7(4):1578-98

Dysregulated serum IL-23 and SIRT1 activity in peripheral blood mononuclear cells of patients with rheumatoid arthritis.

Wendling D, Abbas W, Godfrin-Valnet M, Kumar A, Guillot X, Khan KA, Vidon C, Coquard L, Toussirot E, Prati C, Herbein G

PLoS ONE. 2015 ;10(3):e0119981

Epigenetic control of HIV-1 post integration latency: implications for therapy.

Kumar A, Darcis G, Van Lint C, Herbein G

Clin Epigenetics. 2015 ;7:103

The eEF1A Proteins: At the Crossroads of Oncogenesis, Apoptosis, and Viral Infections.

Abbas W, Kumar A, Herbein G

Front Oncol. 2015 ;5:75

Biological treatments given in patients with rheumatoid arthritis or ankylosing spondylitis modify HAT/HDAC (histone acetyltransferase/histone deacetylase) balance.

Toussirot E, Wendling D, Herbein G,

Joint Bone Spine. 2014 Dec;81(6):544-5

Sirt1 activity in peripheral blood mononuclear cells from patients with rheumatoid arthritis.

Wendling D, Vidon C, Abbas W, Guillot X, Toussirot E, Herbein G

Joint Bone Spine. 2014 Oct;81(5):462-3

Sirtuin 1 activity in peripheral blood mononuclear cells of patients with osteoporosis.

Godfrin-Valnet M, Khan KA, Guillot X, Prati C, Baud L, Abbas W, Toussirot E, Wendling D, Herbein G

Med Sci Monit Basic Res. 2014 Sep;20:142-5

Blockade of BFA-mediated apoptosis in macrophages by the HIV-1 Nef protein.

Abbas W, Khan KA, Kumar A, Tripathy MK, Dichamp I, Keita M, Mahlknecht U, Rohr O, Herbein G

Cell Death Dis. 2014 Feb;5:e1080

CTIP2 is a negative regulator of P-TEFb.

Cherrier T, Le Douce V, Eilebrecht S, Riclet R, Marban C, Dequiedt F, Goumon Y, Paillart JC, Mericskay M, Parlakian A, Bausero P, Abbas W, Herbein G, Kurdistani SK, Grana X, Van Driessche B, Schwartz C, Candolfi E, Benecke AG, Van Lint C, Rohr O

Proc. Natl. Acad. Sci. U.S.A.. 2013 Jul;110(31):12655-60

Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4(+) T cells from HIV-1-infected HAART-treated patients.

Bouchat S, Gatot JS, Kabeya K, Cardona C, Colin L, Herbein G, De Wit S, Clumeck N, Lambotte O, Rouzioux C, Rohr O, Van Lint C

AIDS. 2012 Jul;26(12):1473-82

Inhibition of ER stress-mediated apoptosis in macrophages by nuclear-cytoplasmic relocalization of eEF1A by the HIV-1 Nef protein.

Abbas W, Khan KA, Tripathy MK, Dichamp I, Keita M, Rohr O, Herbein G

Cell Death Dis. 2012 Apr;3:e292

LSD1 cooperates with CTIP2 to promote HIV-1 transcriptional silencing.

Le Douce V, Colin L, Redel L, Cherrier T, Herbein G, Aunis D, Rohr O, Van Lint C, Schwartz C

Nucleic Acids Res.. 2012 Mar;40(5):1904-15

The AP-1 binding sites located in the pol gene intragenic regulatory region of HIV-1 are important for viral replication.

Colin L, Vandenhoudt N, de Walque S, Van Driessche B, Bergamaschi A, Martinelli V, Cherrier T, Vanhulle C, Guiguen A, David A, Burny A, Herbein G, Pancino G, Rohr O, Van Lint C

PLoS ONE. 2011 Apr;6(4):e19084

Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage.

Le Douce V, Herbein G, Rohr O, Schwartz C

Retrovirology. 2010 Apr;7:32

Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection.

Reuse S, Calao M, Kabeya K, Guiguen A, Gatot JS, Quivy V, Vanhulle C, Lamine A, Vaira D, Demonte D, Martinelli V, Veithen E, Cherrier T, Avettand V, Poutrel S, Piette J, de Launoit Y, Moutschen M, Burny A, Rouzioux C, De Wit S, Herbein G, Rohr O, Collette Y, Lambotte O, Clumeck N, Van Lint C

PLoS ONE. 2009 Jun;4(6):e6093